TGTX logo

TG Therapeutics (TGTX) Total Assets

Annual Total Assets

$329.59 M
+$136.01 M+70.27%

31 December 2023

TGTX Total Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Assets

$586.01 M
+$184.81 M+46.06%

30 September 2024

TGTX Quarterly Total Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TGTX Total Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+70.3%+77.0%
3 y3 years-47.3%+43.0%
5 y5 years+294.2%+527.9%

TGTX Total Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-47.3%+70.3%at high+202.7%
5 y5 years-47.3%+294.2%-6.3%+527.9%
alltimeall time-47.3%>+9999.0%-6.3%>+9999.0%

TG Therapeutics Total Assets History

DateAnnualQuarterly
Sept 2024
-
$586.01 M(+46.1%)
June 2024
-
$401.21 M(+7.5%)
Mar 2024
-
$373.32 M(+13.3%)
Dec 2023
$329.59 M(+70.3%)
$329.59 M(-0.4%)
Sept 2023
-
$331.07 M(+49.9%)
June 2023
-
$220.85 M(+11.9%)
Mar 2023
-
$197.36 M(+2.0%)
Dec 2022
$193.57 M(-49.0%)
$193.57 M(-11.2%)
Sept 2022
-
$217.89 M(-13.4%)
June 2022
-
$251.67 M(-16.9%)
Mar 2022
-
$303.03 M(-20.2%)
Dec 2021
$379.63 M(-39.3%)
$379.63 M(-7.3%)
Sept 2021
-
$409.69 M(-14.9%)
June 2021
-
$481.40 M(-12.3%)
Mar 2021
-
$548.70 M(-12.3%)
Dec 2020
$625.64 M(+283.8%)
$625.64 M(+128.5%)
Sept 2020
-
$273.86 M(-7.0%)
June 2020
-
$294.62 M(+189.3%)
Mar 2020
-
$101.85 M(-37.5%)
Dec 2019
$163.01 M(+95.0%)
$163.01 M(+74.7%)
Sept 2019
-
$93.33 M(-12.4%)
June 2019
-
$106.58 M(-9.3%)
Mar 2019
-
$117.54 M(+40.6%)
Dec 2018
$83.62 M(-14.1%)
$83.62 M(-26.9%)
Sept 2018
-
$114.37 M(-18.7%)
June 2018
-
$140.72 M(+16.3%)
Mar 2018
-
$120.99 M(+24.2%)
Dec 2017
$97.38 M(+77.8%)
$97.38 M(-4.3%)
Sept 2017
-
$101.78 M(+0.6%)
June 2017
-
$101.20 M(-17.9%)
Mar 2017
-
$123.26 M(+125.0%)
Dec 2016
$54.78 M(-51.7%)
$54.78 M(-27.6%)
Sept 2016
-
$75.69 M(-20.2%)
June 2016
-
$94.80 M(-5.3%)
Mar 2016
-
$100.06 M(-11.8%)
Dec 2015
$113.47 M(+30.8%)
$113.47 M(-10.9%)
Sept 2015
-
$127.41 M(+3.1%)
June 2015
-
$123.61 M(+5.4%)
Mar 2015
-
$117.27 M(+35.2%)
Dec 2014
$86.75 M(+80.3%)
$86.75 M(+11.9%)
Sept 2014
-
$77.54 M(+37.7%)
June 2014
-
$56.30 M(-3.2%)
Mar 2014
-
$58.17 M(+20.9%)
Dec 2013
$48.11 M(+118.0%)
$48.11 M(-11.4%)
Sept 2013
-
$54.30 M(+204.1%)
June 2013
-
$17.86 M(-16.5%)
Mar 2013
-
$21.39 M(-3.1%)
Dec 2012
$22.07 M(+51.8%)
$22.07 M(-12.5%)
Sept 2012
-
$25.23 M(-4.9%)
June 2012
-
$26.53 M(-2.0%)
Mar 2012
-
$27.07 M(+86.2%)
Dec 2011
$14.54 M(-22.0%)
$14.54 M(-19.5%)
Sept 2011
-
$18.06 M(-1.6%)
June 2011
-
$18.36 M(-1.6%)
Mar 2011
-
$18.65 M(+0.1%)
Dec 2010
$18.64 M
$18.64 M(-2.1%)
Sept 2010
-
$19.03 M(-2.9%)
DateAnnualQuarterly
June 2010
-
$19.59 M(-2.4%)
Mar 2010
-
$20.08 M(+5391.4%)
Dec 2009
$365.70 K(-70.7%)
$365.70 K(-46.4%)
Sept 2009
-
$682.60 K(-40.1%)
June 2009
-
$1.14 M(-27.0%)
Mar 2009
-
$1.56 M(+25.1%)
Dec 2008
$1.25 M(+27.4%)
$1.25 M(+509.6%)
Sept 2008
-
$204.90 K(-78.9%)
June 2008
-
$973.30 K(-34.6%)
Mar 2008
-
$1.49 M(+51.7%)
Dec 2007
$980.60 K(-71.6%)
$980.60 K(-58.4%)
Sept 2007
-
$2.36 M(-55.3%)
June 2007
-
$5.28 M(-43.5%)
Mar 2007
-
$9.34 M(+170.8%)
Dec 2006
$3.45 M(-69.2%)
$3.45 M(-35.1%)
Sept 2006
-
$5.32 M(-30.9%)
June 2006
-
$7.69 M(-17.1%)
Mar 2006
-
$9.28 M(-17.2%)
Dec 2005
$11.21 M(+98.4%)
$11.21 M(-14.3%)
Sept 2005
-
$13.07 M(+403.0%)
June 2005
-
$2.60 M(-40.8%)
Mar 2005
-
$4.39 M(-22.3%)
Dec 2004
$5.65 M(-27.6%)
$5.65 M(-25.9%)
Sept 2004
-
$7.63 M(-14.8%)
June 2004
-
$8.95 M(-10.1%)
Mar 2004
-
$9.96 M(+27.7%)
Dec 2003
$7.80 M(+353.1%)
$7.80 M(+1374.0%)
Sept 2003
-
$529.10 K(-85.3%)
June 2003
-
$3.60 M(-17.6%)
Mar 2003
-
$4.37 M(+154.2%)
Dec 2002
$1.72 M(-2.1%)
$1.72 M(+214.3%)
Sept 2002
-
$547.60 K(-48.2%)
June 2002
-
$1.06 M(-1.1%)
Mar 2002
-
$1.07 M(-39.1%)
Dec 2001
$1.76 M(-44.6%)
$1.76 M(+185.8%)
Sept 2001
-
$615.30 K(-50.0%)
June 2001
-
$1.23 M(-58.4%)
Mar 2001
-
$2.96 M(-6.9%)
Dec 2000
$3.18 M(-20.6%)
$3.18 M(+2.9%)
Sept 2000
-
$3.09 M(+15.3%)
June 2000
-
$2.68 M(-30.4%)
Mar 2000
-
$3.85 M(-3.8%)
Dec 1999
$4.00 M(-38.5%)
$4.00 M(-4.8%)
Sept 1999
-
$4.20 M(-10.6%)
June 1999
-
$4.70 M(-11.3%)
Mar 1999
-
$5.30 M(-18.5%)
Dec 1998
$6.50 M(-26.1%)
$6.50 M(-15.6%)
Sept 1998
-
$7.70 M(-12.5%)
June 1998
-
$8.80 M(+18.9%)
Mar 1998
-
$7.40 M(-15.9%)
Dec 1997
$8.80 M(+266.7%)
$8.80 M(-13.7%)
Sept 1997
-
$10.20 M(+308.0%)
June 1997
-
$2.50 M(+56.3%)
Mar 1997
-
$1.60 M(-33.3%)
Dec 1996
$2.40 M
$2.40 M(-31.4%)
Sept 1996
-
$3.50 M(+20.7%)
June 1996
-
$2.90 M

FAQ

  • What is TG Therapeutics annual total assets?
  • What is the all time high annual total assets for TG Therapeutics?
  • What is TG Therapeutics annual total assets year-on-year change?
  • What is TG Therapeutics quarterly total assets?
  • What is the all time high quarterly total assets for TG Therapeutics?
  • What is TG Therapeutics quarterly total assets year-on-year change?

What is TG Therapeutics annual total assets?

The current annual total assets of TGTX is $329.59 M

What is the all time high annual total assets for TG Therapeutics?

TG Therapeutics all-time high annual total assets is $625.64 M

What is TG Therapeutics annual total assets year-on-year change?

Over the past year, TGTX annual total assets has changed by +$136.01 M (+70.27%)

What is TG Therapeutics quarterly total assets?

The current quarterly total assets of TGTX is $586.01 M

What is the all time high quarterly total assets for TG Therapeutics?

TG Therapeutics all-time high quarterly total assets is $625.64 M

What is TG Therapeutics quarterly total assets year-on-year change?

Over the past year, TGTX quarterly total assets has changed by +$254.95 M (+77.01%)